The finding that FOXA1 activates KDM6A transcription prompted us to investigate whether the KDM6A-ARHGDIB axis mediates the tumour-suppressive effect of FOXA1 in BCa cells. The gene discussed is ARHGDIB; the disease is neoplasm.